ATA137799A - Faktor x-analogon mit verbesserter aktivierbarkeit - Google Patents

Faktor x-analogon mit verbesserter aktivierbarkeit

Info

Publication number
ATA137799A
ATA137799A AT0137799A AT137799A ATA137799A AT A137799 A ATA137799 A AT A137799A AT 0137799 A AT0137799 A AT 0137799A AT 137799 A AT137799 A AT 137799A AT A137799 A ATA137799 A AT A137799A
Authority
AT
Austria
Prior art keywords
analog
factor
improved activation
analog factor
amino acid
Prior art date
Application number
AT0137799A
Other languages
English (en)
Other versions
AT410216B (de
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Priority to AT0137799A priority Critical patent/AT410216B/de
Priority to US09/632,722 priority patent/US6958322B1/en
Priority to AU62807/00A priority patent/AU778571B2/en
Priority to CA002380844A priority patent/CA2380844A1/en
Priority to ES00949465T priority patent/ES2302696T3/es
Priority to PCT/EP2000/007631 priority patent/WO2001010896A2/en
Priority to DE60038312T priority patent/DE60038312T2/de
Priority to AT00949465T priority patent/ATE389013T1/de
Priority to DK00949465T priority patent/DK1238065T3/da
Priority to EP00949465A priority patent/EP1238065B1/de
Publication of ATA137799A publication Critical patent/ATA137799A/de
Application granted granted Critical
Publication of AT410216B publication Critical patent/AT410216B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
AT0137799A 1999-08-10 1999-08-10 Faktor x-analogon mit verbesserter aktivierbarkeit AT410216B (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AT0137799A AT410216B (de) 1999-08-10 1999-08-10 Faktor x-analogon mit verbesserter aktivierbarkeit
US09/632,722 US6958322B1 (en) 1999-08-10 2000-08-04 Factor X analog with an improved ability to be activated
CA002380844A CA2380844A1 (en) 1999-08-10 2000-08-07 Factor x analog with an improved ability to be activated
ES00949465T ES2302696T3 (es) 1999-08-10 2000-08-07 Analogo de factor x con mejor capacidad de activacion.
AU62807/00A AU778571B2 (en) 1999-08-10 2000-08-07 Factor X analog with an improved ability to be activated
PCT/EP2000/007631 WO2001010896A2 (en) 1999-08-10 2000-08-07 Factor x analog with an improved ability to be activated
DE60038312T DE60038312T2 (de) 1999-08-10 2000-08-07 Faktor x-analog mit einer verbesserten fähigkeit, aktiviert zu werden
AT00949465T ATE389013T1 (de) 1999-08-10 2000-08-07 Faktor x-analoge mit verbesserter fähigkeit zur aktivierung
DK00949465T DK1238065T3 (da) 1999-08-10 2000-08-07 Faktor X-analog med forbedret evne til aktivering
EP00949465A EP1238065B1 (de) 1999-08-10 2000-08-07 Faktor x-analoge mit verbesserter fähigkeit zur aktivierung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0137799A AT410216B (de) 1999-08-10 1999-08-10 Faktor x-analogon mit verbesserter aktivierbarkeit

Publications (2)

Publication Number Publication Date
ATA137799A true ATA137799A (de) 2002-07-15
AT410216B AT410216B (de) 2003-03-25

Family

ID=3512576

Family Applications (2)

Application Number Title Priority Date Filing Date
AT0137799A AT410216B (de) 1999-08-10 1999-08-10 Faktor x-analogon mit verbesserter aktivierbarkeit
AT00949465T ATE389013T1 (de) 1999-08-10 2000-08-07 Faktor x-analoge mit verbesserter fähigkeit zur aktivierung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT00949465T ATE389013T1 (de) 1999-08-10 2000-08-07 Faktor x-analoge mit verbesserter fähigkeit zur aktivierung

Country Status (9)

Country Link
US (1) US6958322B1 (de)
EP (1) EP1238065B1 (de)
AT (2) AT410216B (de)
AU (1) AU778571B2 (de)
CA (1) CA2380844A1 (de)
DE (1) DE60038312T2 (de)
DK (1) DK1238065T3 (de)
ES (1) ES2302696T3 (de)
WO (1) WO2001010896A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040480A1 (en) * 2001-07-20 2003-02-27 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
MX2007001294A (es) 2004-08-17 2008-03-04 Zlb Behring Gmbh Polipeptidos modificados que dependen de vitamina k.
EP1728798A1 (de) 2005-06-01 2006-12-06 ZLB Behring GmbH Blutgerinnungsfaktor X Polypeptide mit veränderten Aktivierungseigenschaften
MX2008006313A (es) 2005-11-15 2008-11-06 Philadelphia Children Hospital Metodos y composiciones para modular la hemostasia.
EP1820508A1 (de) * 2006-02-21 2007-08-22 CSL Behring GmbH Polypeptide des Gerinnfaktors X mit geänderten Aktivierungseigenschaften
AU2008253230B2 (en) 2007-05-22 2013-07-18 Takeda Pharmaceutical Company Limited Preparative purification process for human furin
TWI492951B (zh) * 2007-12-31 2015-07-21 Baxter Int 表現人類凝血因子的基因轉殖非人類動物及其用途
US20110072524A1 (en) * 2009-08-04 2011-03-24 Baxter International Inc. Transgenic Mouse Lacking Endogenous FVIII and VWF - A Model of Hemophilia A
EP2760887B1 (de) 2011-09-30 2024-10-23 The Children's Hospital of Philadelphia Zusammensetzungen und verfahren zur hämostasenmodulierung
US9145552B2 (en) 2012-07-25 2015-09-29 Catalyst Biosciences, Inc. Modified factor X polypeptides and uses thereof
EP2950813B1 (de) 2013-01-31 2019-09-04 Pfizer Inc Zusammensetzung und verfahren zur entgegenwirkung gegen faktor-xa-hemmung
FR3001729B1 (fr) * 2013-02-04 2015-03-06 Lab Francais Du Fractionnement Mutants du facteur x
JP6429885B2 (ja) 2013-09-24 2018-11-28 ファイザー・インク 組換えヒト凝固第ｘａ因子タンパク質の不均一集団を含む組成物
US10676731B2 (en) 2014-08-19 2020-06-09 The Children's Hospital Of Philadelphia Compositions and methods for modulating factor IX function
FR3050992A1 (fr) * 2016-05-06 2017-11-10 Lab Francais Du Fractionnement Mutants du facteur x

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT366916B (de) 1980-04-02 1982-05-25 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen
US4501731A (en) 1983-06-27 1985-02-26 Tishkoff Garson H Treatment of disparate bleeding disorders with factor X zymogen
AT382783B (de) 1985-06-20 1987-04-10 Immuno Ag Vorrichtung zur applikation eines gewebeklebstoffes
US5597799A (en) 1990-09-04 1997-01-28 Cor Therapeutics, Inc. Recombinant agents affecting thrombosis
EP0785273A1 (de) 1990-11-26 1997-07-23 Genetics Institute, Inc. Gepaarte basische Aminosäuren konvertierendes Enzym und dafür kodierende DNA Sequenz
US5621039A (en) 1993-06-08 1997-04-15 Hallahan; Terrence W. Factor IX- polymeric conjugates
DE4325872C1 (de) 1993-08-02 1994-08-04 Immuno Ag Virusinaktivierte Faktor Xa-Präparation
AT401270B (de) 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
AT404838B (de) 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
AT405516B (de) * 1997-02-27 1999-09-27 Immuno Ag Faktor x-analoge mit modifizierter proteasespaltstelle
AT405517B (de) 1997-02-27 1999-09-27 Immuno Ag Faktor x-deletionsmutanten und analoge davon

Also Published As

Publication number Publication date
AT410216B (de) 2003-03-25
ES2302696T3 (es) 2008-08-01
DE60038312D1 (de) 2008-04-24
EP1238065A2 (de) 2002-09-11
US6958322B1 (en) 2005-10-25
DE60038312T2 (de) 2009-03-26
WO2001010896A3 (en) 2002-07-11
AU6280700A (en) 2001-03-05
CA2380844A1 (en) 2001-02-15
EP1238065B1 (de) 2008-03-12
AU778571B2 (en) 2004-12-09
DK1238065T3 (da) 2008-07-07
ATE389013T1 (de) 2008-03-15
WO2001010896A2 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
ATA137799A (de) Faktor x-analogon mit verbesserter aktivierbarkeit
ATE310009T1 (de) Reaktionssysteme zur herstellung von n- (phosphonomethyl)glyzin verbindungen
DE69818077D1 (de) Ein kombinationsverfahren zur herstellung von ethylen, ethylbenzol und styrol
DE60108042D1 (de) Prozesse zur Herstellung von pulverförmigen Schlagzäh-Modifizierern
DE69909003D1 (de) Verfahren zur Herstellung von Polyamiden
DE69920642D1 (de) Photokatalysator enthaltend organisch-inorganisch hybrid Zusammensetzungen, und dessen Herstellungsverfahren
ATE201203T1 (de) Chirale methylphenyloxazolidinone
EP0588351A3 (de) Harte, gegen Verschleiss widerstandsfähige Beschichtung und Verfahren zur Herstellung derselben.
DE69901569D1 (de) Humane antikörper gegen faktor ix/ixa
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
DE59709869D1 (de) Neue substanzbibliothek und damit hergestellte supramolekulare komplexe
DE60239842D1 (de) Verfahren zur Herstellung von 10,11-dihydro-10-oxo-5h-dibenzoÄb,fÜazepin-5-carboxamid
DE50001758D1 (de) Verfahren und Anlage zur Herstellung von 1,2-Dichlorethan
DE60100217D1 (de) Verfahren zur Herstellung von hochkonzentrierten Kohlendioxid
MXPA02004829A (es) Metodo para la sintesis estereoselectiva de aminoacidos ciclicos.
ES2099828T3 (es) Derivado aminoacido.
DE59506870D1 (de) Verfahren zur Herstellung von Polyamiden auf Basis von alpha,omega-Dinitrilen
DE60103560D1 (de) Prozess zur herstellung von paclitaxel
DE69924026D1 (de) Coenzym zur herstellung von l-carnitin
ATE242763T1 (de) Methoximinophenylessigsäureamide
DE60043559D1 (de) Verfahren zur Herstellung von Elektroden
PT1246790E (pt) Bases de mannich de 1- e 2-naftol substituido
DE60104789D1 (de) Verfahren zur Herstellung von 2,4,5-Trialkylbenzaldehyden
JP2000186092A5 (de)
ATE331733T1 (de) Metallhaltige ribonukleotidpolypeptide

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee